The Meaningless Meaning of Mean Heart Dose in Mediastinal Lymphoma in the Modern Radiation Therapy Era
Bradford S. Hoppe(Jacksonville College), Stella Flampouri(University of North Florida), James E. Bates(The University of Texas MD Anderson Cancer Center), Nancy P. Mendenhall(University of Florida Health), Marwan Shaikh(University of Florida), Richard T. Hoppe(Stanford University), Christopher G. Morris(University of Florida Health), Zuofeng Li(University of Florida Health), Debbie Louis(University of Florida Health), Meng Wei Ho(University of Florida Health)
Cited by 76
Related Papers
Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
|Journal of Clinical Oncology|2011|657
Non-Hodgkin’s Lymphomas
|Journal of the National Comprehensive Cancer Network|2010|329
American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology
|International Journal of Radiation Oncology*Biology*Physics|2017|201
Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC
|Blood|2021|170
Therapy-Related Cardiac Risk in Childhood Cancer Survivors: An Analysis of the Childhood Cancer Survivor Study
|Journal of Clinical Oncology|2019|147